Key Financial Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Key Financial Inc’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31K	Hold	55	–	–	﹤0.01%	1132
2026 Q1	$1.45K	Hold	55	–	–	﹤0.01%	1208
2025 Q4	$1.59K	Hold	55	–	–	﹤0.01%	1206
2025 Q3	$1.59K	Hold	55	–	–	﹤0.01%	1220
2025 Q2	$1.34K	Hold	55	–	–	﹤0.01%	1238
2025 Q1	$1.14K	Buy	55 +20	+57%	+$502	﹤0.01%	1214
2024 Q4	$824	Hold	35	–	–	﹤0.01%	1249
2024 Q3	$896	Hold	35	–	–	﹤0.01%	1209
2024 Q2	$822	Hold	35	–	–	﹤0.01%	1202
2024 Q1	$1.01K	Hold	35	–	–	﹤0.01%	1185
2023 Q4	$1.15K	Hold	35	–	–	﹤0.01%	1166
2023 Q3	$975	Hold	35	–	–	﹤0.01%	1197
2023 Q2	$1.19K	Hold	35	–	–	﹤0.01%	1220
2023 Q1	$1.05K	Hold	35	–	–	﹤0.01%	1025
2022 Q4	$1.15K	Hold	35	–	–	﹤0.01%	1016
2022 Q3	$1K	Hold	35	–	–	﹤0.01%	999
2022 Q2	$1K	Hold	35	–	–	﹤0.01%	983
2022 Q1	$2K	Hold	35	–	–	﹤0.01%	905
2021 Q4	$2K	Hold	35	–	–	﹤0.01%	804
2021 Q3	$3K	Hold	35	–	–	﹤0.01%	751
2021 Q2	$3K	Buy	+35	New	+$2.98K	﹤0.01%	728

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Key Financial Inc's ARKG Position: Q2 2026 in Review

Key Financial Inc held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 55 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Key Financial Inc first reported a position in ARKG in Q2 2021 and has held it in 21 quarters since. The position peaked at $3K in Q3 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Key Financial Inc held 55 shares of ARK Genomic Revolution ETF worth $2.31K as of Q2 2026.
Key Financial Inc left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1132 holding.
Key Financial Inc first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 21 quarters since.
Key Financial Inc's ARK Genomic Revolution ETF position peaked at $3K in Q3 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.